Most Americans want the Biden administration to protect intellectual property rights at the World Trade Organization (WTO) and express concerns about waiving those rights, finds a new poll commissioned by the Bayh-Dole Coalition.
Why it matters: In 2022, the U.S. Trade Representative (USTR) agreed to a waiver of WTO IP protection for COVID vaccines. Now, USTR is considering an extension of the waiver to include COVID diagnostics and therapeutics.
The key finding: 7 in 10 respondents said it’s important for the Biden administration to preserve WTO IP protections, and most said it’s very important, finds a Morning Consult poll of 2,202 U.S. adults conducted Dec. 22-24.
China is a concern: 68% said U.S. adversaries like China should not be able to replicate American-made technologies without permission from the inventors—with only 11% disagreeing and 21% saying they don’t know.
Vote for IP protection: 66% would be inclined to vote for a candidate who prioritizes stronger IP rights, while 11% said they prefer a candidate who weakens IP rights.
IP waivers aren’t necessary—and the COVID vaccine IP waiver was never used because IP was never a barrier to global distribution, 19 House Democrats recently told USTR.
BIO agrees: “There is no credible evidence supporting the need for an expanded TRIPS waiver,” said BIO Chief Policy Officer John Murphy.
More Health News:
American Cancer Society: 2024 is first year U.S. expects more than 2M new cases of cancer
“This trend is largely affected by the aging and growth of the population and by a rise in diagnoses of 6 of the 10 most common cancers—breast, prostate, endometrial, pancreatic, kidney, and melanoma. (The other 4 top 10 cancers are lung, colon and rectum, bladder, and non-Hodgkin lymphoma.) In 2024, over 611,000 deaths from cancer are projected for the US. That’s more than 1,600 deaths from cancer each day.”